GRI Bio, Inc. Announces Special Meeting of Stockholders on January 19, 2024

TL;DR

<b>GRI Bio, Inc. is holding a virtual special meeting of stockholders on January 19, 2024, urging them to vote by proxy.</b>

AI Summary

GRI BIO, Inc. (GRI) filed a Proxy Statement (DEF 14A) with the SEC on January 2, 2024. GRI Bio, Inc. will hold a special meeting of stockholders on January 19, 2024, at 11:00 a.m. Eastern time. The meeting will be conducted virtually via live audio webcast on the internet. Stockholders can attend, vote, and submit questions at www.virtualshareholdermeeting.com/GRI2024SM. The company encourages stockholders to vote by proxy. The proxy statement provides details about the meeting and business to be conducted.

Why It Matters

For investors and stakeholders tracking GRI BIO, Inc., this filing contains several important signals. The virtual format aims to increase stockholder participation and reduce costs and environmental impact. Stockholder participation is crucial for the company's governance and decision-making processes.

Risk Assessment

Risk Level: — GRI BIO, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for a special meeting, with no immediate financial or operational risks disclosed.

Analyst Insight

Stockholders should review the proxy statement and vote their shares, preferably by proxy, for the upcoming special meeting.

Key Numbers

• January 19, 2024 — Special Meeting Date (Date of the special meeting of stockholders.)
• 11:00 a.m. Eastern time — Meeting Time (Time the special meeting will commence.)

Key Players & Entities

• GRI BIO, Inc. (company) — Registrant and filer of the proxy statement.
• January 19, 2024 (date) — Date of the special meeting of stockholders.
• 11:00 a.m. Eastern time (time) — Time the special meeting will begin.
• www.virtualshareholdermeeting.com/GRI2024SM (url) — Website to attend the virtual special meeting.
• W. Marc Hertz, Ph.D. (person) — President and Chief Executive Officer of GRI Bio, Inc.

FAQ

Industry Context

GRI Bio, Inc. operates in the pharmaceutical preparations industry, focusing on developing therapeutics.

Regulatory Implications

The filing is a proxy statement under Section 14(a) of the Securities Exchange Act of 1934, requiring specific disclosures for shareholder meetings.

What Investors Should Do

1. Review the proxy statement for details on the business to be conducted at the special meeting.
2. Vote your shares, either in person at the virtual meeting or by proxy (internet, telephone, mail).
3. Ensure your proxy is submitted to have your shares represented at the meeting.

Key Dates

• 2024-01-19: Special Meeting of Stockholders — To conduct company business and allow stockholders to vote.

Year-Over-Year Comparison

This is a new filing (DEF 14A) for a special meeting, not a comparison to a prior period's financial results.

Key Financial Figures

• $1.00 — shares of our common stock of at least $1.00 per share (also referred to as the "min
• $1.00 m — ket is then in compliance with Nasdaq's $1.00 minimum bid price requirement. If our co
• $5.00 — he price of our common stock were below $5.00 at such time, shares of our common stoc
• $5 million — y institutions with assets in excess of $5 million or individuals with net worth in excess
• $1 million — individuals with net worth in excess of $1 million (not including the value of his or her
• $0.2 million — y residence) or annual income exceeding $0.2 million or $0.3 million jointly with their spou
• $0.3 million — annual income exceeding $0.2 million or $0.3 million jointly with their spouse). For transac

Filing Documents

• specialmeetingproxy_dec2023.htm (DEF 14A) — 174KB
• image_0.jpg (GRAPHIC) — 19KB
• screenshot2023-12x18185922a.jpg (GRAPHIC) — 106KB
• screenshot2023-12x18190025a.jpg (GRAPHIC) — 126KB
• 0001824293-23-000187.txt (&nbsp;) — 521KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 15 ADDITIONAL INFORMATION 16 APPENDIX A CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Appendix A-1 APPENDIX B PROXY CARD Appendix B- 1 i GRI BIO, INC. 2223 AVENIDA DE LA PLAYA, SUITE 208 LA JOLLA, CA 92037 PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON JANUARY 19, 2024 This proxy statement (the "Proxy Statement") is furnished to stockholders of GRI Bio, Inc., a Delaware corporation (the "Company," "we," "us," or "our"), in connection with the solicitation of proxies by our board of directors for use at a special meeting of stockholders to be held on January 19, 2024, and at any adjournment or postponement thereof (our "Special Meeting"). Our Special Meeting will be held at 1100 a.m. Eastern time via a live webcast at www.virtualshareholdermeeting.comGRI2024SM . On or about January 2, 2024, we will commence mailing of the proxy materials which are also available at www.proxyvote.com . The proxy materials are being sent to stockholders who owned our common stock at the close of business on December 18, 2023, the record date for the Special Meeting (the "Record Date"). This Proxy Statement contains important information for you to consider when deciding how to vote on the matters brought before the meeting. Please read it carefully. Why am I receiving these materials We sent you this Proxy Statement because our board of directors is soliciting your proxy to vote at our Special Meeting. This Proxy Statement summarizes the information you need to vote at our Special Meeting. You do not need to attend our Special Meeting to vote your shares. What proposals will be voted on at the Special Meeting Stockholders will vote on two proposals at the Special Meeting 1. The approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of Company common stock by a ratio of not l

View Full Filing

View this DEF 14A filing on SEC EDGAR